Dividend
-
-
-
-
-
-
-
Cipher Pharmaceuticals Responds to Request for Comment from IIROC
-
-
-
-
-
-
-
Cipher Pharmaceuticals Reports Q1 2016 Financial Results
-
-
-
-
-
-
-
Cipher Pharmaceuticals Announces Approvals of Astion Acquired Barrier Creams by Health Canada and the Medicines Evaluation Board
-
-
-
-
-
-
-
Cipher Pharmaceuticals Launches a Foam Preparation of Bionect
-
-
-
-
-
-
-
Cipher Pharmaceuticals announces acceptance of 510(k) submission for Dermadexin™ by FDA
-
-
-
-
-
436,668 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

